Repurposed Anti-Inflammatory Pills Show Modest Promise Against Debilitating Skin Disease
A new systematic review finds that phosphodiesterase-4 inhibitors achieved clinical response in 53.4 percent of hidradenitis suppurativa patients with a ...
A new systematic review finds that phosphodiesterase-4 inhibitors achieved clinical response in 53.4 percent of hidradenitis suppurativa patients with a ...
A multicenter study of 104 patients finds that lower-dose and higher-dose bevacizumab produce similar radiographic outcomes in brain radiation necrosis, ...
A new meta-analysis of twenty studies covering nearly 292,000 people finds that long-term metformin use is significantly associated with peripheral ...
A new machine learning method called DCSE predicts side effects of drug combinations and introduces more realistic evaluation standards that ...
A global pharmacovigilance analysis of 354 pregnancies found no unexpected safety signals with the complement inhibitor ravulizumab, with outcomes consistent ...
A retrospective case series of twelve patients with bipolar disorder documents oxcarbazepine-associated skin reactions, which emerged mainly within the first ...
A two-stage analysis combining FDA adverse event reports with Japanese claims data found aripiprazole associated with a significantly lower risk ...
A 608-patient multicenter study in China found that delamanid-containing regimens for multidrug-resistant tuberculosis showed a safety profile consistent with clinical ...
A nationally representative Swiss survey finds that 2.5 percent of the population has used GLP-1 receptor agonists, mostly for weight ...
A new meta-analysis of six randomized controlled trials finds that the 36 mg maintenance dose of the oral GLP-1 agonist ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine